Brief: Cannara Biotech Q3 EPS CAD 0.04
Jul 28 (Reuters) - Cannara Biotech Q3 revenue CAD 27.3 million.
Recent news on Cannara Biotech
See all newsBrief: Cannara Biotech - Enters Amended Syndicated Credit Agreement With BMO And Td
Cannara Biotech Q3 revenue tops estimates on expanded distribution
Canada Research Roundup: Cannara Biotech ,Equinox Gold , Winpak
Brief: Cannara Announces Strategic C$6.3 Million Non-Brokered Private Placement Priced At C$2.10 Per Common Share
Brief: Cannara Biotech Delivers Q4